Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 403,300 | 1,458,500 | 729,400 | 1,257,100 | 1,317,600 |
| Marketable Securities | 1,108,700 | 560,100 | 447,100 | 1,066,900 | 583,100 |
| Receivables | 2,024,000 | 1,665,000 | 1,468,700 | 1,400,300 | 1,403,900 |
| Inventories | 1,384,100 | 1,264,900 | 1,093,500 | 1,067,800 | 1,171,500 |
| Other current assets | 1,232,300 | 839,900 | 994,500 | 592,700 | 332,100 |
| TOTAL | $6,152,400 | $5,788,400 | $4,733,200 | $5,384,800 | $4,808,200 |
| Non-Current Assets | |||||
| PPE Net | 3,472,600 | 3,073,200 | 2,632,500 | 2,305,100 | 2,381,000 |
| Investments And Advances | 544,900 | 724,300 | 586,700 | 601,400 | 1,337,800 |
| Other Non-Current Assets | 2,559,400 | 1,512,600 | 1,378,500 | 1,298,800 | 1,107,600 |
| TOTAL | $6,576,900 | $5,310,100 | $4,597,700 | $4,205,300 | $4,826,400 |
| Total Assets | $12,729,300 | $11,098,500 | $9,330,900 | $9,590,100 | $9,634,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 715,300 | 524,900 | 479,100 | 456,400 | 462,900 |
| Accrued Expenses | 421,300 | 419,000 | 408,600 | 332,900 | 287,600 |
| Other current liabilities | 1,192,800 | 930,900 | 770,900 | 779,900 | 620,400 |
| TOTAL | $5,187,200 | $4,825,900 | $3,443,600 | $3,217,400 | $3,420,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 833,000 | 604,200 | 570,500 | 571,300 | 396,600 |
| Other Non-Current Liabilities | 1,036,400 | 1,132,800 | 1,261,900 | 935,900 | 456,300 |
| TOTAL | $2,035,500 | $1,948,700 | $2,021,800 | $1,654,100 | $1,187,800 |
| Total Liabilities | $7,222,700 | $6,774,600 | $5,465,400 | $4,871,500 | $4,573,900 |
| Shareholders' Equity | |||||
| Common Shares | 34,300 | 34,000 | 33,900 | 33,700 | 33,200 |
| Retained earnings | 6,858,900 | 5,944,500 | 5,240,700 | 5,119,300 | 4,794,900 |
| Other shareholders' equity | -1,006,800 | -553,000 | -657,800 | 45,700 | 157,700 |
| TOTAL | $5,506,600 | $4,323,900 | $3,865,500 | $4,718,600 | $5,026,300 |
| Total Liabilities And Equity | $12,729,300 | $11,098,500 | $9,330,900 | $9,590,100 | $9,600,200 |